Sign in
Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy
Journal article

Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy

H A Harfi and S A Malik
Annals of allergy, Vol.69(2), pp.147-150
08/1992
PMID: 1510287

Abstract

Antibody Formation Chediak-Higashi Syndrome - immunology Chediak-Higashi Syndrome - surgery Chediak-Higashi Syndrome - therapy Child Humans Immunity, Cellular Male Neutrophils - physiology Splenectomy
A 10-year-old boy with Chediak-Higashi syndrome in accelerated phase failed to respond to treatment with ascorbic acid, vincristine, and prednisone. Splenectomy resulted in clinical, hematologic, and immunologic improvement: his leukocyte chemotactic and phagocytic functions returned to normal. We suggest that splenectomy be considered in treatment of the accelerated phase of Chediak-Higashi syndrome unresponsive to other forms of therapy.

Metrics

1 Record Views

Details